Palantir Stock Is Taking a Hit: These Key Figures From the AI Company's Earnings Report Highlight Why I'm Still Not Buying

Palantir reported Q1 revenue growth of 85% year over year to $1.63 billion and raised full-year 2026 revenue guidance to a midpoint of $7.66 billion, implying 71% growth. However, the article highlights decelerating forward indicators: closed TCV growth slowed to 61% from 138% in Q4, and U.S. commercial RDV growth has also cooled over the last three quarters. Despite the strong operating results, the stock fell almost 7% as the valuation remains extremely rich at roughly 60x sales and about 150x earnings.

Analysis

The core issue is not near-term demand, but the sequencing of monetization versus sentiment. When a company is priced for multiple years of compounding, any evidence that deal quality is shortening or backlog conversion is normalizing can compress the multiple before revenue actually slows. That creates a classic “good quarter, bad stock” setup: operating metrics can still inflect higher while the market begins discounting the first derivative of those metrics instead of the headline growth rate.

The second-order effect is that a weaker Palantir tape can spill over to the broader AI software cohort, especially names trading on narrative rather than current cash flow. That matters most for enterprise AI vendors selling mission-critical workflows at premium valuations, where investors have implicitly assumed a long runway of hypergrowth and expanding contract duration. If buyers become more duration-sensitive, the market will increasingly favor infrastructure beneficiaries with clearer usage-based spend visibility over application-layer software with lumpy procurement cycles.

The most important catalyst is not the next revenue print but whether the backlog and TCV trend stabilize over the next 1-2 quarters. If contract duration continues to shorten, reported growth can remain strong while the forward book quietly weakens, which is exactly the kind of lag that catches momentum holders offside. Conversely, a re-acceleration in U.S. commercial RDV or a disclosure showing materially stronger large-deal conversion could force a sharp short-covering rally given how crowded the stock has become.

The contrarian read is that the market may be over-discounting a temporary mix shift rather than a true demand break. If management is prioritizing shorter-cycle deployments to clear a demand queue, near-term TCV can understate future revenue capacity even as operating leverage improves. That said, with the multiple still implying perfection, the burden of proof is on the bulls; the stock can stay expensive, but it becomes much more vulnerable to any evidence that growth is simply decelerating from extraordinary to merely excellent.

Key Decisions for Investors

• Maintain a tactical short PLTR bias into the next 1-2 earnings cycles; use call spreads or put spreads rather than outright shares to limit squeeze risk. Best risk/reward is on any rally back toward prior support, where implied expectations reset higher but the forward-booking trend remains the key downside trigger.
• Pair trade: long NVDA / short PLTR over a 1-3 month horizon. If AI spend remains healthy, capital should migrate toward the infrastructure layer with clearer monetization, while PLTR carries more multiple compression risk if bookings quality continues to soften.
• Use a bearish options structure on PLTR into the next quarterly report: buy 1-2 quarter put spreads financed partially by selling far OTM puts. This captures the risk that the market re-rates the stock on any further TCV/RDV deceleration without paying full premium for an outright collapse.
• For investors already long PLTR, trim 25-50% on strength and re-enter only if U.S. commercial RDV growth re-accelerates sequentially. The stock’s valuation leaves little room for a 1-2 quarter gap between revenue momentum and backlog momentum.
• Watch for a relative-long basket of NVDA/INTC versus PLTR only if broader AI sentiment stabilizes; otherwise the cleaner trade is simply to stay underweight high-multiple AI software until the market proves that contract duration is not the leading indicator.